Michael Fein, DPM
Podiatrist · Bethel, CTNPI 1356375778
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 237 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 37 manufacturers reported payments, led by Smith+Nephew at 29.7% of the total. Reporting peaked in 2019 at $1,898 and has fallen 53.1% since, to $890 in 2025. Among podiatrist clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 237 payments — averaging $38.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$3K
- Organogenesis Inc.$678
- Gramercy Extremity Orthopedics LLC$670
- Treace Medical Concepts, Inc.$654
- Stryker$573
- Averitas Pharma Inc.$558
- plus $3K from 31 others
Across 6 payments — averaging $8333.33 each. An ownership or investment interest held by the physician or an immediate family member.
- Gramercy Extremity Orthopedics LLC$50K
What the payments were for
- Consulting fees$1001%
- Travel & lodging$601%
- Food & beverage$8,69596%
- Education$1682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 76 | $2,683 |
| Organogenesis Inc. | 22 | $678 |
| Gramercy Extremity Orthopedics LLC | 4 | $670 |
| Treace Medical Concepts, Inc. | 8 | $654 |
| Stryker(2 entities) | 15 | $573 |
| Averitas Pharma Inc. | 26 | $558 |
| GRT US Holding, Inc. | 15 | $409 |
| Medtronic(2 entities) | 6 | $375 |
| Osiris Therapeutics Inc. | 3 | $292 |
| Amgen(2 entities) | 3 | $250 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $221 |
| Bioventus LLC | 7 | $169 |
| Gotham Surgical Solutions & Devices, Inc. | 1 | $144 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $131 |
| Convatec Inc. | 6 | $121 |
| Shockwave Medical, Inc | 1 | $110 |
| Comsort, Inc | 1 | $100 |
| Polaris Technology Solutions LLC | 1 | $92 |
| Paratek Pharmaceuticals, Inc. | 6 | $90 |
| Triad Life Sciences Inc. | 3 | $82 |
| Acera Surgical, Inc. | 1 | $79 |
| Melinta Therapeutics, LLC | 4 | $70 |
| Nabriva Therapeutics, PLC | 4 | $65 |
| Acell, Inc. | 2 | $59 |
| Celularity Inc. | 1 | $55 |
| Merck | 3 | $53 |
| Paragon 28, Inc. | 1 | $31 |
| Sanara Medtech Inc. | 1 | $27 |
| KCI USA, Inc. | 1 | $25 |
| Integra Lifesciences Corporation | 1 | $24 |
| Kerecis Limited | 1 | $24 |
| My01 Inc. | 1 | $23 |
| Medartis Inc. | 1 | $22 |
| Heron Therapeutics, Inc. | 1 | $20 |
| Lifenet Health | 1 | $19 |
| Misonix Inc | 1 | $13 |
| Globus Medical | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,024 in reported general payments places this provider in the 90th percentile of 119 podiatrist providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Econazole Nitrate | 13 | $835 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $363 |
| Ketoconazole | 12 | $302 |
| Doxycycline Hyclate | 14 | $189 |
| Cefadroxil | 15 | $156 |
| Mupirocin | 21 | $147 |
| Terbinafine Hcl | 19 | $119 |
| Gabapentin | 18 | $68 |
| Meloxicam | 31 | $40 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Bethel
- Jamie OtfinoskiBethel$7K
- Peter BlumeNew Haven$481K
- Robert DavisBridgeport$427K
- David NovickiMilford$67K
- Shane ReynoldsNorwalk$14K
- Eric LevineNorwich$12K
- Paul BetschartDanbury$10K
- Tehreem SajjadNew Britain$9K
- Christopher YardanWallingford$8K
- Devang PatelNorwalk$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.